| Literature DB >> 36186750 |
Hassan Choudry1, Fateen Ata2, Muhammad Naveed Naveed Alam3, Ruqaiya Ruqaiya3, Mahammed Khan Suheb4, Muhammad Qaiser Ikram3, Muhammad Muzammil Chouhdry3, Muaz Muaz3.
Abstract
BACKGROUND: Despite its high prevalence, migraine remains underdiagnosed worldwide. A significant reason is the knowledge gap in physicians regarding diagnostic criteria, clinical features, and other clinical aspects of migraine. AIM: To measure the knowledge deficit in physicians and medical students and to assess the prevalence of migraine in the same population.Entities:
Keywords: Epidemiology; Headache disorders; Knowledge; Knowledge study; Migraine; Prevalence; Public health
Year: 2022 PMID: 36186750 PMCID: PMC9516540 DOI: 10.5662/wjm.v12.i5.414
Source DB: PubMed Journal: World J Methodol ISSN: 2222-0682
Figure 1Knowledge of indications of migraine prophylaxis in physicians. The answers highlighted in red indicates distractors which were not true indications of prophylaxis and added as distractor for more accuracy and to lower bias.
Figure 2Knowledge of triggers of migraine in physicians. The answers highlighted in red indicate distractors which were not true triggers of migraine and were added as distractor for more accuracy and to lower bias.
General characteristics and responses of all subjects
|
|
|
| Gender | Females: 88 (50.3) |
| Males: 87 (49.7) | |
| Age (yr) | Mean: 25.7 ± 4.1 |
| Grade | Medical student: 39 (22.3) |
| House officers: 74 (42.3) | |
| Non-trainee medical officers: 17 (9.7) | |
| Trainee medical officer: 38 (21.7) | |
| Senior registrar: 4 (2.3) | |
| Assist professor: 2 (1.1) | |
| Professor: 1 (0.6) | |
| Specialty of doctors | Medicine & allied: 98 (56) |
| Surgery & allied: 51 (29.1) | |
| Others: 9 (5.1) | |
| Not answered: 17 (9.7) | |
| Do you have migraine? | Yes: 22 (12.6) |
| No: 109 (62.3) | |
| Maybe: 44 (25.1) | |
| Confirmed migraine after reading the ICHD-3 criteria of all 3 types of migraine | Migraine without aura: 36 (20.6) |
| Migraine with aura: 9 (5.1) | |
| Chronic migraine: 3 (1.7) | |
| No migraine: 127 (72.6) | |
| Consulted any physician | GP: 19 (10.8) |
| Medical specialist: 22 (12.6) | |
| Neurologist: 10 (5.7) | |
| Ophthalmologist: 19 (10.8) | |
| Other: 9 (5.1) | |
| No consultation: 110 (62.8) | |
| Physician able to diagnose migraine | Yes: 45 (25.7) |
| No: 9 (5.1) | |
| Maybe: 9 (5.1) | |
| Never consulted: 112 (64) | |
| Knowledge of diagnostic criteria of migraine | Heard and remember it: 66 (37.7) |
| Heard about it but don't remember: 85 (48.6) | |
| Never heard about it: 24 (13.7) | |
| Knowledge of prophylaxis of migraine | I know its indications: 59 (33.7) |
| I knew its indications but don't remember: 70 (40) | |
| Know only that it exists: 26 (14.8) | |
| Don't know about it at all: 20 (11.4) | |
| Aura is essential for migraine? | Yes: 66 (37.7) |
| No: 83 (46.8) | |
| Not sure: 26 (14.7) | |
| Duration of standard prophylactic therapy of migraine? | Do not know: 100 (57.1) |
| 1 mo: 10 (5.7) | |
| 3 mo: 27 (15.4) | |
|
| |
| 12 mo: 14 (8) | |
| Monthly headache rate for prophylaxis | ≥ 2 per mo: 64 (36.6) |
| ≥ 3 per mo: 52 (29.7) | |
|
| |
| ≥ 5 per mo: 15 (8.6) | |
| Not available: 1 (0.6) | |
| Used abortive (migraine patients only) | Yes: 12 (25) |
| No: 34 (70.8) | |
| Maybe: 2 (4.2) | |
| Used prophylactic therapy (migraine patients only) | Yes: 9 (18.7) |
| No: 38 (79.2) | |
| Not sure: 1 (2.1) |
Chosen as the standard in accordance with American Headache Society (AHS) guidelines.
Figure 3Belief in the myth that aura is an integral part of migraine diagnosis.
Results of analysis between groups based on consult-seeking behaviors and migraine diagnoses
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
| Gender | Females: 54 (49.5%); Males: 55 (50.5%) | Females: 34 (51.5%); Males: 32 (48.5%) | 0.8 | Females: 28 (58.3%); Males: 20 (41.7%) | Females: 60 (47.2%); Males: 67 (52.7%) | 0.19 |
| Knowledge of diagnostic criteria | Remember: 37 (33.9%); Don’t remember:72 (66.1%) | Remember: 29 (43.9%); Don’t remember: 37 (56.1%) | 0.24 | Remember: 25 (52.1%); Don’t remember: 23 (47.9%) | Remember: 41 (32.3%); Don’t remember: 86 (67.7%) |
|
| Know prophylaxis indications | Yes: 31 (28.4%); No:78 (71.6%) | Yes: 38 (34.9%); No: 28 (42.4%) | 0.05 | Yes: 21 (43.7%); No: 27 (56.2%) | Yes: 38 (29.9%); No: 89 (70.1%) | 0.08 |
| Aura essential for diagnosis? | Yes: 65 (59.6%); No or not sure: 44(40.4%) | Yes: 27 (40.9%); No or not sure: 39 (51.1%) |
| Yes: 22 (45.8%); No or not sure: 26 (54.2%) | Yes: 70 (55.1%); No or not Sure: 57 (44.9%) | 0.27 |
| Consulted | Neurologist: 10 (15.2%); Other doctor(s): 56 (84.8%); None: 0 (0%) | Neurologist:8 (16.7%); Other doctors:21 (43.7%); None: 19 (39.6%) | Neurologist: 2 (1.6%); Other doctors: 35 (27.6%); None: 90 (70.9%) |
| ||
| Monthly attack cutoff for prophylaxis | Correctly Identified: 33 (30.3%); Could not Identify: 75 (68.8%) | Correctly Identified: 10 (15.1%); Could not Identify: 56 (84.9%) | 0.02 | Correctly Identified: 16; Could not Identify: 32 | Correctly Identified: 27 (21.4%); Could not Identify: 99 (78.6%) | 0.11 |
| Know correct duration of prophylaxis? | Yes: 28 (25.7%); No: 81 (74.3%) | Yes :20 (30.3%); No: 46 (69.7%) | 0.5 | Yes: 13 (27%); No: 35 (73%) | Yes: 35 (27.5%); No: 92 (72.5%) | 0.94 |
| Frequency of headache attacks (per month) | None: 31 (28.4%); ≤ 1: 39(35.8%); 2: 17 (15.6%); 3: 6 (5.5%); ≥ 4: 16 (14.7%) | None: 13 (19.7%); ≤ 1: 22 (33.3%); 2: 13 (19.7%); 3: 8 (12.1%); ≥ 4: 10 (15.1%) | 0.4 | None: 4 (8.3%); ≤ 1: 16 (33.3%); 2: 9 (18.7%); 3: 6 (12.5%); ≥ 4: 13 (27.1%) | None: 40 (31.5%); ≤ 1: 45 (35.4%); 2: 21 (15.7%); 3: 8 (6.3%); ≥ 4: 13 (2.4%) |
|
| Total triggers recognized | Median: 4, IQR: 5 | Median: 3, IQR: 4 | 0.29 | Median: 3.5, IQR: 3 | Median: 4, IQR: 5 | 0.297 |
| Total indications recognized | Median: 2, IQR: 1 | Median: 1, IQR: 1 | 0.21 | Median: 1, IQR: 1 | Median: 1, IQR: 1 | 0.22 |
| Distractor(s) recognized as triggers | Yes: 47 (43.1%); No: 62 (56.9%) | Yes: 29 (43.9%); No: 37 (56.1%) | 0.91 | Yes: 22 (45.8%); No: 26 (54.2%) | Yes: 54 (42.5%); No: 73 (57.5%) | 0.69 |
| Distractor(s) recognized as Indications | Yes: 37 (33.9%); No: 71 (65.1%) | Yes: 17 (25.7%); No: 49 (74.2%) | 0.23 | Yes: 16 (33.3%); No: 32 (66.7%) | Yes: 38 (22.1%); No: 88 (87.9%) | 0.68 |
| Migraineurs | Migraineurs: 19 (17.4%); Non-migraineurs: 90 (82.5%) | Migraineurs: 29 (43.9%); Non-migraineurs: 37 (56.1%) | < 0.001; OR: 3.7 (95%CI: 1.8-7.5) | |||
Indicates statistically significant results.
Monthly headache rate ≥ 4 was chosen as standard for initiation of prophylaxis according to American Headache Society (AHS) guidelines.
A 6-mo duration of prophylaxis was chosen as standard according to AHS guidelines.
IQR: Inter-quartile range; OR: Odd’s ratio; CI: Confidence interval.
Subgroup analysis among migraineurs based on awareness of their disease
|
|
|
| |
|
|
|
|
|
| Gender | Females: 13 (61.9%); Males: 8 (38.1%) | Females: 15 (55.5%); Males: 12 (45.5%) | 0.65 |
| Diagnostic criteria | Remember: 12 (57.1%); don’t remember: 9 (42.9%) | Remember: 13 (48%); don’t remember: 14 (52%) | 0.53 |
| Know prophylaxis indications | Know indications: 11 (52.4%); do not know about either prophylaxis or its indications: 10 (47.6%) | Know indications: 10 (37%); do not know about either prophylaxis or its indications: 17 (63%) | 0.44 |
| Aura essential for diagnosis? | No: 13 (61.9%); yes or not sure: 8 | No: 13 (48.1%); yes or not sure: 14 (51.9%) | 0.34 |
| Consulted | Neurologist: 6 (28.6%); Any other physician: 11 (52.4%); Didn't consult: 4 (19%) | Neurologist: 2 (7.4%); Any other physician: 10 (37%); Didn’t consult: 15 |
|
| Monthly attack cutoff for prophylaxis | Correctly identified: 5 (23.8%); Couldn't identify: 16 (76.2%) | Correctly identified: 11 (40.7%); Couldn't identify: 16 (59.2%) | 0.22 |
| Know duration of prophylaxis | Correctly identified: 6 (28.5%); Couldn't identify:15 (71.4%) | Correctly identified: =7 (33.3%); Couldn’t identify: 20 (66.7%) | 0.83 |
| Respondent’s frequency of attacks (per month) | None: 1 (4.8%); ≤ 1: 8 (38.1%); 2: 2 (9.5%); 3: 3 (14.3%); ≥ 4: 7 (33.3%) | None: 3 (11.1%); ≤ 1: 8 (29.6%); 2: 7 (25.9%); 3: 3 (11.1%); ≥ 4: 6 (22.2%) | 0.5 |
| Average no of triggers recognized | Median: 3, IQR: 3 | Median: 4, IQR: 3 | 0.32 |
| Average no of indications recognized | Median: 1, IQR: 1 | Median: 2, IQR: 1 | 0.17 |
Indicates statistically significant results.
IQR: Inter-quartile range; OR: Odd’s ratio; CI: Confidence interval.